Renée Vassilos

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Seastar Medical, Inc. manufactures and supplies medical devices. It offers medical device that cures inflammation-based diseases and conditions. The company was founded by James P. Sherblom in July 2007 and is headquartered in Denver, CO.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Delphos International Ltd. engages in the provision of advisory services. Its services include capital raising and transaction advisory. The company was founded by William A. Delphos in 1987 and is headquartered in Washington, DC.

The Carter Center, Inc. provides human rights protection services. The firm's services include resolving conflicts; advancing democracy, human rights, and economic opportunity; preventing diseases; improving mental health care; and teaching farmers to increase crop production. The company was founded by James E. Carter, Jr. and Rosalynn Smith Carter in 1982 and is headquartered in Atlanta, GA.

Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell.

Akula Energy Ventures LLC (Akula Energy Ventures) is a venture capital firm founded in 2008 by Srikant Akula. The firm headquartered in Jersey City, New Jersey.

Root Capital, Inc. provides investment and financial services to small and growing agricultural businesses. Its products include coffee, cocoa, fruits and vegetables and other products. The firm is an agricultural lender that grows rural prosperity in poor, environmentally vulnerable places in Africa and Latin America by lending capital, delivering financial training and strengthening market connections for small and growing agricultural businesses. The company was founded by William F. Foote in 1999 and is headquartered in Cambridge, MA.

Farmshelf Corp. designs, owns, and manages modular urban farms that enable customers to grow food such as fruits and vegetables. The company was founded by Andrew James Shearer and Manan Rajesh Gandhi and is headquartered in Brooklyn, NY.

Anvil Informatics, Inc. provides silico drug discovery and drug development solutions. The company was founded on December 20, 2000 and is headquartered in Burlington, MA.

Compound Asset Management, Inc. engages in the investment of real estate. Its brands include Cityfunds, and QOZ Business. The company was founded by Jesse Stein and Janine Yorio and is headquartered in New York, NY.

The U.S. International Development Finance Corp. operates as America’s development bank. The firm offers equity and debt financing, political risk insurance and technical development products. The company was founded in 2019 and is headquartered in Washington, DC.

Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million.